Xia-ying SI, Xiu-ning YUE, Xin WANG, et al. Effect of Shugan Jieyu Capsules Combined with Repetitive Transcranial Magnetic Stimulation on Neuroendocrine Function During Perimenopause[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(1): 163-168.
DOI:
Xia-ying SI, Xiu-ning YUE, Xin WANG, et al. Effect of Shugan Jieyu Capsules Combined with Repetitive Transcranial Magnetic Stimulation on Neuroendocrine Function During Perimenopause[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(1): 163-168. DOI: 10.13422/j.cnki.syfjx.20190132.
Effect of Shugan Jieyu Capsules Combined with Repetitive Transcranial Magnetic Stimulation on Neuroendocrine Function During Perimenopause
To discuss the clinical effect of Shugan Jieyu capsules combined with repetitivetranscranial magnetic stimulation (rTMS) on depression during perimenopause and neuroendocrine function.
Method:
2
One hundred and thirty-two patients were divided into control groupand observation groupby random number table. Patients (65 cases) in observation group got sertraline hydrochloride tablets
50 mg/time
2 times/days. Patients (67 cases) in control group got Shugan Jieyu capsules after breakfast and dinner
2 grains/time
and treatment of rTMS
20 minutes/time
1 time/day. And one course of treatment was 5 days
there were a 2-day interval between two courses. And there were a total of 4 courses in the two groups. Both groups were continuously treated for8 weeks. Degree of depression was evaluated by Hamilton depression scale-17 (HAMD-17). Before and after treatment
scores of Hamilton anxiety scale (HAMA)
quality index of sleep in Pittsburgh (PSQI)
Kupperman and syndrome of kidney deficiency and stagnation of liver were graded. Levels of follicle stimulating hormone (FSH)
Luteinizing hormone (LH)
estradiol (E
2
)
5-serotonin (5-HT)
dopamine (DA)
norepinephrine (NE) and 5-hydroxyindolyl acetic acid (5-HIAA) were detected
and the safety was evaluated.
Result:
2
According to the variance analysis of repeated measurements
after treatment
score of HAMD-17 decreased (
P
<
0.01). At the 8
th
day after treatment
score of HAMD-17of observation groupwas lower than that in control group (
P
<
0.01). And scores of syndrome of kidney deficiency and stagnation of liver
HAMA
PSQI and Kupperman of observation group were lower than those in control group (
P
<
0.01). And the total rate of depression in observation group was 95.52%
which was higher than 81.54% in control group (
χ
2
=6.405
P
<
0.05). And the total rate of traditional Chinese medicine(TCM) syndromes in observation group was 92.54%
which was higher than 78.46% in control group (
χ
2
=5.304
P
<
0.05). After treatment
levels of FSH and LH were lower than those in control group (
P
<
0.01).
Conclusion:
2
Shugan Jieyu capsules combined with repetitivetranscranial magnetic stimulation can ameliorate symptoms of depression and anxiety
havea bettereffect than Sertraline hydrochloride tablets
and can regulate levels of sex hormone and monoamine neurotransmitter.